I’ve spent 11 years in pharma commercial operations and managed markets. If I see one more slide deck promising “unprecedented networking opportunities” without a list of who is actually in the room, I’m walking out. You don’t need more business cards. You need a formulary placement.
If you are in market access, your calendar is likely bloated with events that prioritize prescriber reach over payer strategy. Let’s be clear: prescribers decide what they want to write, but managed care pharmacy directors and health system C-suite executives decide what actually gets filled. Here is how I categorize the high-impact events, and more importantly, how you should be planning for them.
Stop Confusing Prescriber Reach with Market Access
There is a fundamental difference between a medical congress for clinicians and a managed care pharmacy event. At a clinical congress, you are selling the data to the person holding the pen. At a formulary development conference, you are selling the value proposition to the person holding the budget.
If your strategy involves lobbying for access, stop spending your travel budget on physician-focused trade shows. You need to be where the P&T (Pharmacy and Therapeutics) committee stakeholders and health system executives gather to discuss affordability, HTA (Health Technology Assessment) pressure, and utilization management.
The “Big Three” I Track in My Spreadsheet
I keep a running spreadsheet of every major conference. I don’t track the speaker count; I track the decision-maker density. Here is how I break down the organizations you should be vetting:
1. AMCP: The Managed Care Pharmacy Engine
If you are looking for a managed care pharmacy event, AMCP is the industry standard for a reason. This is where you meet the people who actually build the formularies. When you engage here, do not talk about your clinical trials for 30 minutes. They have already seen the data.
Focus your strategy on the “How.” How does your product change the managed care pharmacy workflow? How does it affect their medical policy? If you can’t answer that, you’re just noise. My tip: Use these meetings to gather intelligence on their specific utilization management triggers—prior authorizations, step edits, and coverage criteria.
2. The Health Management Academy (THMA): The C-Suite Play
THMA is a different beast entirely. You aren’t meeting the pharmacy manager here; you are meeting the leaders of the largest integrated health systems in the country. These are the people responsible for the health system’s P&L.
The conversation shifts from “Does it work?” to “Does it work for our bottom line and our patient population?” You need to be prepared to talk about evidence generation that bridges the gap between clinical outcomes and operational cost. Digital tools in evidence generation are becoming critical here—executives want to see real-world data, not just static 52-week study outcomes.
3. ACCC: Closing the Gap in Clinical Execution
The ACCC is vital for specialized therapy areas, particularly oncology. It’s not just about getting on the formulary; it’s about ensuring that the site of care can actually execute that formulary choice. If the practice can’t figure out the reimbursement pathway, the product sits on the shelf, even if it is “covered.”
The “Monday Morning” Test
When I walk out of any of these conferences, I always ask myself one question: “What would I do differently on Monday morning?” If the answer is “nothing,” the conference was a waste of time and company money.
Before you commit to the next event, prepare your “Monday” list:
- Payer Intelligence: Did I find out which specific P&T committees are reviewing our therapeutic class in Q3?
- Evidence Gaps: Did I hear a recurring objection about our value dossier that I need to pass to our HEOR team?
- Digital Compliance: Did I engage with the evolving digital tools for reimbursement that payers are using?
The “Digital Compliance” Elephant in the Room
Speaking of digital tools, you need to be aware of how your stakeholders interact with your digital presence. Whether you are using a site-level portal for providers or https://pharmashots.com/33979/pharma-market-access-conferences-2026/ an evidence generation platform for payers, understand the landscape. You’ll often see Cookie Law Info UI elements on these sites—the banners that manage privacy and tracking.
If you think that’s just legal fluff, you are missing the point. Those tools represent how your stakeholders are controlling their data. If you are scraping data for “market research” without understanding the digital consent architecture, you are going to alienate the very people you are trying to reach. Pay attention to how they interact with technology; it tells you everything about their appetite for digital innovation.
Addressing HTA Pressure and Pricing
Let’s talk about the buzzwords. I hate “synergy” and “streamline.” They mean nothing. In the real world, the only thing that matters is HTA pressure and pricing. Payers are under extreme pressure to lower net prices while maintaining clinical outcomes.
At these conferences, look for the breakout sessions that discuss:
Strategic Takeaways for Your Next Event
If you want to move from “just another vendor” to a strategic partner, your behavior at these events must change. Stop overpromising ROI. Stop talking about “streamlining your processes.” Start talking about the specific problems your payers face regarding formulary execution.
1. Build the Spreadsheet: Track names, titles, and specific questions they asked. If you don’t track who you actually meet, you’ll be repeating the same mistakes next year.
2. Prepare the Evidence: Bring real-world data that supports your pricing. If you can’t show how your drug lowers the total cost of care, you aren’t participating in a managed care strategy—you are just asking for a rebate reduction.
3. Observe the Room: Pay attention to the sessions that are packed versus the ones that are empty. If a session on HTA pressure is standing-room-only, you should be there, listening for the pain points. That is where your next strategic pivot will come from.
Managed care strategy isn’t about being present at every managed care pharmacy event on the circuit. It’s about being present at the right ones with a clear, data-backed value proposition that addresses the hard reality of modern formulary development. See you on the floor—just don’t try to use the word ‘synergy’ with me.
